Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

2
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

3
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional abnormalities of cardiac sympathetic innervation in athletes with nonischaemic left ventricular scar and exercise-related ventricular arrhythmias.

European heart journal open·2026
Same author

Transvenous and Subcutaneous Implantable Cardioverter Defibrillator in Arrhythmogenic Cardiomyopathy: Insights from a single-center experience.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Beyond arrhythmias: Exploring heart failure in arrhythmogenic cardiomyopathy.

International journal of cardiology·2026
Same author

Interpreting the athlete's ECG to prevent sudden death: An old tool in constant evolution.

International journal of cardiology·2026
Same author

Persistent sinus node dysfunction after biatrial heart transplantation successfully managed with CT-guided leadless atrial pacing: a case report.

European heart journal. Case reports·2026
Same author

Sudden Death in Young Competitive Athletes Due to Arrhythmogenic Cardiomyopathy: A 4-Decade National Referral Center Experience.

Circulation. Arrhythmia and electrophysiology·2026

Related Experiment Video

Updated: Jun 10, 2025

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

3.9K

Left Ventricular Non-Compaction: Evolving Concepts.

Raimondo Pittorru1, Manuel De Lazzari1, Federico Migliore1

  • 1Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35128 Padua, Italy.

Journal of Clinical Medicine
|October 16, 2024
PubMed
Summary

Left ventricular non-compaction (LVNC) is a rare heart condition. Research suggests focusing on compact layer thinning, not just trabeculation, for better diagnosis and management of LVNC.

Keywords:
cardiomyopathieshypertrabeculationleft ventricular non-compactionspongy myocardium

More Related Videos

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

27.8K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.2K

Related Experiment Videos

Last Updated: Jun 10, 2025

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

3.9K
Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

27.8K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.2K

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Medical Diagnostics

Background:

  • Left ventricular non-compaction (LVNC) is characterized by prominent trabeculation and a thin compact layer.
  • Current diagnostic criteria, like the Petersen index, focus on trabeculation, which is not specific to LVNC.
  • The European Society of Cardiology (ESC) previously removed 'LVNC cardiomyopathy' but evolving views are restoring it.

Purpose of the Study:

  • To review current knowledge on LVNC pathogenesis, genetics, and diagnostic criteria.
  • To offer modern insights into the clinical and prognostic relevance of compact layer thinning.
  • To update understanding of LVNC and guide future research and patient management.

Main Methods:

  • Literature review of existing research on LVNC.
  • Analysis of proposed pathogenetic hypotheses, including 'allometric growth'.
  • Evaluation of current and evolving diagnostic criteria and their limitations.

Main Results:

  • Excessive trabeculation is a phenotypic trait, not specific to LVNC.
  • A proposed mechanism involves congenital underdevelopment of the compact layer, impairing systolic function.
  • Future research should prioritize compact layer thinning over trabeculation for clinical relevance.

Conclusions:

  • LVNC diagnosis and understanding are evolving, moving beyond simple trabeculation.
  • Compact layer development and thinning are critical factors in LVNC pathophysiology.
  • Focusing on compact layer abnormalities may improve patient management and prognosis.